TwinBeech Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-127,028
Closed -$1.9M 955
2023
Q3
$1.9M Buy
+127,028
New +$2.64M 0.04% 418
2023
Q1
Sell
-23,151
Closed -$1.22M 947
2022
Q4
$1.22M Sell
23,151
-3,637
-14% -$177K 0.02% 500
2022
Q3
$1.21M Buy
+26,788
New +$1.15M 0.03% 423
2021
Q4
Sell
-9,385
Closed -$516K 864
2021
Q3
$516K Buy
+9,385
New +$491K 0.04% 426
2021
Q1
Sell
-7,896
Closed -$497K 709
2020
Q4
$497K Buy
+7,896
New +$490K 0.08% 289

Other funds holding SILK

TwinBeech Capital's SILK Position: Q4 2023 in Review

TwinBeech Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 127,028 shares — an estimated $1.9M sold.

TwinBeech Capital first reported a position in SILK in Q4 2020 and held it in 5 quarters. The position peaked at $1.9M in Q3 2023. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • TwinBeech Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • TwinBeech Capital sold 127,028 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $1.9M.
  • TwinBeech Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • TwinBeech Capital's Silk Road Medical, Inc. Common Stock position peaked at $1.9M in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on TwinBeech Capital's 13F filing for Q4 2023, filed 14 Feb 2024.